{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:11:59Z","timestamp":1780056719346,"version":"3.54.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1124\/jpet.114.218644","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T05:44:38Z","timestamp":1414561478000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Antiparasitic Drug, Potassium Antimony Tartrate, Inhibits Tumor Angiogenesis and Tumor Growth in Nonsmall-Cell Lung Cancer"],"prefix":"10.1016","volume":"352","author":[{"given":"Beibei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.218644_bib1","first-page":"879","article-title":"Vascular reactions of normal and malignant tissues in Vivo. VI. The role of hypotension in the action of components of podophyllin on transplanted sarcomas","volume":"14","author":"Algire","year":"1954","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl","key":"10.1124\/jpet.114.218644_bib2","doi-asserted-by":"crossref","first-page":"II365","DOI":"10.1161\/01.CIR.92.9.365","article-title":"Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo","volume":"92","author":"Asahara","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.218644_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1124\/jpet.114.218644_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/cb600362d","article-title":"Inhibition of angiogenesis by the antifungal drug itraconazole","volume":"2","author":"Chong","year":"2007","journal-title":"ACS Chem Biol"},{"key":"10.1124\/jpet.114.218644_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3322\/caac.20075","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1124\/jpet.114.218644_bib6","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.218644_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.114.218644_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.218644_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1124\/jpet.114.218644_bib10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.218644_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.218644_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"Gupta","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.114.218644_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1124\/jpet.114.218644_bib14","doi-asserted-by":"crossref","first-page":"a009183","DOI":"10.1101\/cshperspect.a009183","article-title":"Receptor tyrosine kinase-mediated angiogenesis","volume":"5","author":"Jeltsch","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/jpet.114.218644_bib15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing","volume":"5","author":"Jones","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.218644_bib16","first-page":"113","article-title":"Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review)","volume":"20","author":"Kanda","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1124\/jpet.114.218644_bib17","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.218644_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","article-title":"Src kinases as therapeutic targets for cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/jpet.114.218644_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.218644_bib20","first-page":"1071","article-title":"Potassium antimonyl tartrate induces reactive oxygen species-related apoptosis in human myeloid leukemic HL60 cells","volume":"20","author":"Lecureur","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.114.218644_bib21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2141.2002.03863.x","article-title":"Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells","volume":"119","author":"Lecureur","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.114.218644_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/bbrc.1999.1586","article-title":"Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells","volume":"264","author":"Lee","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.218644_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1124\/jpet.114.218644_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.218644_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0404.1998.tb00609.x","article-title":"Tumor angiogenesis\u2014a new therapeutic target in gliomas","volume":"97","author":"Lund","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1124\/jpet.114.218644_bib26","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-06-3043","article-title":"KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"13","author":"Massarelli","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1647","article-title":"The role of focal-adhesion kinase in cancer - a new therapeutic opportunity","volume":"5","author":"McLean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.114.218644_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-11-2683","article-title":"Inhibition of MEK and PI3K\/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas","volume":"18","author":"Migliardi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib29","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1083\/jcb.97.5.1648","article-title":"In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices","volume":"97","author":"Montesano","year":"1983","journal-title":"J Cell Biol"},{"key":"10.1124\/jpet.114.218644_bib30","doi-asserted-by":"crossref","first-page":"44045","DOI":"10.1074\/jbc.M111.278754","article-title":"The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells","volume":"286","author":"Nacev","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218644_bib31","first-page":"2431","article-title":"Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma","volume":"6","author":"Niki","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/0008-5472.CAN-08-2531","article-title":"Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways","volume":"69","author":"Pang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib33","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1158\/0008-5472.CAN-09-0755","article-title":"Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis","volume":"69","author":"Pang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/8466","article-title":"Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity","volume":"5","author":"Parman","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.218644_bib35","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2011.39.7646","article-title":"Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine\/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer","volume":"30","author":"Paz-Ares","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.114.218644_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/jpet.114.218644_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-07-2799","article-title":"Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity","volume":"68","author":"Pyun","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib38","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1242\/dev.093641","article-title":"Lgr4-mediated Wnt\/\u03b2-catenin signaling in peritubular myoid cells is essential for spermatogenesis","volume":"140","author":"Qian","year":"2013","journal-title":"Development"},{"key":"10.1124\/jpet.114.218644_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","article-title":"Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis","volume":"305","author":"Ranpura","year":"2011","journal-title":"JAMA"},{"key":"10.1124\/jpet.114.218644_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"VEGF and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Saharinen","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.114.218644_bib41","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.218644_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-4894(66)90040-3","article-title":"Biological disposition of antibilharzial antimony drugs. II. Antimony fate and uptake by Schistosoma haematobium eggs in man","volume":"18","author":"Schulert","year":"1966","journal-title":"Exp Parasitol"},{"key":"10.1124\/jpet.114.218644_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrc3366","article-title":"Controlling escape from angiogenesis inhibitors","volume":"12","author":"Sennino","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.114.218644_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1124\/jpet.114.218644_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1124\/jpet.114.218644_bib46","first-page":"2506","article-title":"Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas","volume":"5","author":"Takahama","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.114.218644_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.critrevonc.2011.05.003","article-title":"Challenges in the current antiangiogenic treatment paradigm for patients with non-small cell lung cancer","volume":"82","author":"Wozniak","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1124\/jpet.114.218644_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.2309","article-title":"Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways","volume":"17","author":"Zhang","year":"2011","journal-title":"Nat Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.218644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:56:30Z","timestamp":1739987790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524189057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022356524189057"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.218644","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Antiparasitic Drug, Potassium Antimony Tartrate, Inhibits Tumor Angiogenesis and Tumor Growth in Nonsmall-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.218644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}